Skip to main content
. 2021 Jul 20;27(20):5576–5585. doi: 10.1158/1078-0432.CCR-21-1083

Figure 3.

Figure 3. RNA positivity at diagnosis and outcome for different risk groups, stratified according RMS2005. Outcome for different risk groups is given as treated (continuous line) and stratified for RNA positivity (RNA+) and RNA negativity (RNA−) at diagnosis. A and B, EFS and OS, respectively, for SR group; please note that no P value is reported since there is no mortality in the SR group. C and D, EFS and OS, respectively, for HR group. E and F, EFS and OS, respectively, for metastatic disease group.

RNA positivity at diagnosis and outcome for different risk groups, stratified according RMS2005. Outcome for different risk groups is given as treated (continuous line) and stratified for RNA positivity (RNA+) and RNA negativity (RNA−) at diagnosis. A and B, EFS and OS, respectively, for SR group; please note that no P value is reported since there is no mortality in the SR group. C and D, EFS and OS, respectively, for HR group. E and F, EFS and OS, respectively, for metastatic disease group.